Welcome guest
Ethical issues in the pharmaceutical industry: an analysis of US newspapers
George P. Sillup, Stephen J. Porth
International Journal of Pharmaceutical and Healthcare Marketing
2008
163 - 180
10.1108/17506120810903953
Emerald Group Publishing Limited
The authors wish to thank the Saint Joseph's University's Pedro Arrupe Center for Business Ethics for their support.
Please select from the following options:
View HTML
|
View PDF
(109 KB)
Purpose – The purpose of this study is to analyze newspaper coverage of ethical issues in the pharmaceutical industry.
Design/methodology/approach – The top five US newspapers were audited over two years and yielded 376 articles, which appeared as front-page stories or editorials. First, headlines were analyzed and categorized as positive, negative, or neutral toward the industry. Next, the full-text of each article was analyzed and ethical issues in each article were categorized. Then, articles were evaluated to determine whether the opposing point of view was included. Finally, comparisons were made between the identified issues and the issues cited by PhRMA, the pharmaceutical industry's trade association.
Findings – Analysis of the ethical issues revealed different results for the two years. In 2004, the most common issues covered were drug pricing, data disclosure and importation/reimportation. In 2005, drug safety was the number one issue, due to Vioxx
Practical implications – Pharmaceutical companies need to take action to address the negative impression about them.
Originality/value – This research establishes a practical methodology to evaluate newspaper coverage of ethical issues involving the pharmaceutical industry.
Drug administration,
Ethics,
Health and safety,
Mass media,
Newspapers,
Pharmaceuticals industry
Research paper
www.emeraldinsight.com/10.1108/17506120810903953